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4-(Azidomethyl)pyrazole-3-carboxylic acid ethyl esters react with cyanoacetamides in THF solution in 
the presence of t-BuOK resulting in the formation of 5-oxo-4,5,7,9-tetrahydropyrazolo[3,4-e][1,2,3]-
triazolo[1,5-a][1,3]diazepine-3-carboxamides. 
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 Tandem reactions are an effective tool in modern organic synthesis that has been successfully used to 
construct a variety of acyclic, carbo- and heterocyclic systems [2-6]. In the field of heterocyclic compound 
chemistry, for instance, tandem condensation of alkyl 2-azidobenzoates with activated acetonitriles is a basis for 
efficient synthesis of [1,2,3]triazolo[1,5-a]quinazoline derivatives [7-9], such as the known selective serotonin 
5-HT6 receptor antagonists [7] and inhibitors of the biosynthesis of teichoic acid, a component of the cell wall 
of many gram-positive bacteria [9]. Among the azidobenzoate pyrazole analogs such transformations are 
described only for ethyl 5-azido-1-methyl-4-pyrazolecarboxylate, reaction of which with activated nitriles gave 
3-substituted pyrazolo[4,3-e][1,2,3]triazolo[1,5-a]pyrimidines [10]. To us it seemed worthwhile to exploit the 
synthetic potential of tandem reactions of other pyrazole functional derivatives with cyanoacetic acid amides to 
obtain new condensed heterocyclic compounds. 
 In this work, 4-(azidomethyl)pyrazole-3-carboxylic acid esters 2a-c, formed in essentially quantitative 
yields by reacting 4-chloromethylpyrazole-3-carboxylic acid ethyl ester 1a-c [11] with sodium azide in DMF 
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compounds 2a-c is the location of the azide group in the γ-position relative to the ester group, which is an 
important prerequisite for the formation of a seven-membered heterocyclic system. Of the compounds with this 
placement of substituents, only 2-azidobenzylacetate have been previously used in cyclocondensation with 
cyanoacetamide [12]. 
 We have found that 4-(azidomethyl)pyrazole-3-carboxylic acid esters 2a-c react with cyanoacetamides 
3a-e in refluxing THF in the presence of t-BuOK, forming pyrazolo[3,4-e][1,2,3]triazolo[1,5-a]diazepine-
3-carboxamides 4a-g in 53-67% yields. This transformation is presumably an example of a tandem reaction that 
begins with the cycloaddition to the azido group of a carbanion, generated from cyanoacetamide, and the 
formation of an intermediate polyfunctional triazole A, susceptible to the formation of the diazepine cycle due 































































50°C, 3 h , 5 h
 
1a, 2a, 4a,b R = Me; 1b, 2b, 4c-e R = Ph; 1c, 2c, 4f,g R = 4-BrC6H4; 3a, 4c R1 = H; 
3b, 4d R1 = Ph; 3c, 4a R1 = 4-ClC6H4; 3d, 4b,e,f R1 = 4-MeC6H4; 3e, 4g R1 = 4-MeOC6H4 
 
 Compounds 4a-g are the first representatives of a previously unknown heterocyclic system, which holds 
promise as a scaffold for the design of bioactive substances owing to the presence of endo- and exocyclic amide 
fragments in its structure. The structure of target compounds was confirmed by various analytical methods 
(Tables 1-4). It should be noted that the absence of signals in the downfield region (160-190 ppm) of the 13C NMR 
spectra excludes the possibility for the formation of the alternative Claisen condensation/cycloaddition tandem 
reaction products, 9-oxo-5,7,9,10-tetrahydropyrazolo[3,4-e]tetrazolo[1,5-a]azepine-10-carboxamides. Employing 
the APT method for the analysis of 13C NMR spectra and comparison with published data [8, 13] allowed for a 
comparatively accurate assignment of signals to the corresponding carbon atoms in the triazolodiazepine cycle: 
C-3 (127-128 ppm), C-3a (137-139), C-5 (157-159), C-5a (141-143), C-8a (116-118), C-9 (42-43 ppm). 
 Thus, in this study the efficiency of using the condensation of 4-(azidomethyl)pyrazole-3-carboxylic 
acid ethyl ester with cyanoacetamides for one-pot synthesis of derivatives of a previously unknown pyr-





 IR spectra were acquired on a UR-20 spectrophotometer in KBr pellets. 1Н and 13С NMR spectra were 
recorded on a Bruker Avance DRX-500 spectrometer (500 and 125 MHz, respectively) in DMSO-d6 with TMS as 
internal standard. Mass spectra were acquired on an Agilent LC/MSD SL mass spectrometer; Zorbax SB-C18  
 
TABLE 1. Physicochemical Characteristics of the Synthesized 
Compounds 2а-c, 4a-g 
 





formula С H N 



















































































*An oily viscous substance. 
 
 









IR spectrum, ν, cm–1 Mass 
spectrum, 









































column 4.6×15 mm, 1.8 m (PN 82(c)75-932); mobile phase А: MeCN–Н2О, 95:5, 0.1% trifluoroacetic acid, 
mobile phase B: 0.1% aqueous trifluoroacetic acid; flow: 3 ml/min; injection volume: 1 l; UV detection: 215, 254, 
285 nm; atmospheric-pressure CI, scan range m/z 80-1000. Elemental analysis was performed on a Perkin Elmer 
CHN Analyzer at the analytical laboratory of the Institute of Organic Chemistry of the National Academy of 
Sciences of Ukraine. Melting points were determined on a Kofler hot bench and are uncorrected.  
 Compounds 1а-с were prepared according to the published method [11]. 
 4-Chloromethyl-1-methyl-1Н-pyrazole-3-carboxylic Acid Ethyl Ester (1a). Yield 75%. Colorless 
crystalline substance. Mp 64-66°С (EtOH). IR spectrum, ν, cm-1: 1725 (C=O). 1Н NMR spectrum, δ, ppm (J, 
Hz): 1.29 (3Н, t, J = 7.2, CH3); 3.89 (3H, s, NCH3); 4.27 (2H, q, J = 7.2, CH2); 4.81 (2Н, s, СН2); 7.96 (1Н, s, 




TABLE 3. 1Н NMR Spectra of Compounds 2a-c, 4a-g 
 
Com- 




1.29 (3Н, t, J = 7.4, CH3); 3.91 (3H, s, CH3); 4.27 (2Н, q, J = 7.4, CH2); 
4.49 (2H, s, CH2); 7.93 (1H, s, H-5) 
2b 1.33 (3Н, t, J = 7.2, CH3); 4.33 (2Н, q, J = 7.2, CH2); 4.60 (2H, s, CH2); 
7.41 (1Н, t, J = 7.8, H Ph); 7.55 (2Н, t, J = 8.0, H Ph); 7.87 (2Н, d, J = 8.0, H Ph); 
8.74 (1H, s, H-5) 
2с 1.33 (3Н, t, J = 6.8, CH3); 4.34 (2Н, q, J = 6.8, CH2); 4.59 (2H, s, CH2); 
7.73 (2Н, d, J = 8.4, H Ar); 7.85 (2Н, d, J = 8.4, H Ar); 8.76 (1H, s, H-5) 
4a 3.94 (3H, s, CH3); 5.73 (2H, s, 9-CH2); 7.39 (2Н, d, J = 7.6, H Ar); 
7.86 (2Н, d, J = 7.6, H Ar); 7.96 (1H, s, H-8); 9.95 (1H, s, NH); 10.72 (1H, s, NH) 
4b 2.26 (3H, s, CH3); 3.94 (3H, s, CH3); 5.72 (2H, s, 9-CH2); 7.13 (2Н, d, J = 7.8, H Ar); 
7.68 (2Н, d, J = 7.8, H Ar); 7.96 (1H, s, H-8); 9.96 (1H, s, NH); 10.47 (1H, s, NH) 
4c 5.77 (2H, s, 9-CH2); 7.42-8.08 (7H, m, H Ph, NH2); 8.72 (1H, s, H-8); 10.08 (1H, s, NH) 
4d 5.82 (2H, s, 9-CH2); 7.10-8.04 (10H, m, H Ph); 8.74 (1H, s, H-8); 10.24 (1H, s, NH); 
10.57 (1H, s, NH) 
4e 2.27 (3H, s, CH3); 5.81 (2H, s, 9-CH2); 7.13 (2Н, d, J = 7.2, H Ar); 
7.43-7.58 (3H, m, H Ar); 7.70 (2Н, d, J = 8.0, H Ar); 7.85 (2Н, d, J = 8.0, H Ar); 
8.83 (1H, s, H-8); 10.23 (1H, s, NH); 10.51 (1H, s, NH) 
4f 2.27 (3H, s, CH3); 5.82 (2H, s, 9-CH2); 7.14 (2Н, d, J = 8.0, H Ar); 
7.70 (2Н, d, J = 8.0, H Ar); 7.76 (2Н, d, J = 8.5, H Ar); 7.83 (2Н, d, J = 8.5, H Ar); 
8.78 (1H, s, H-8); 10.26 (1H, s, NH); 10.49 (1H, s, NH) 
4g 3.73 (3H, s, CH3); 5.81 (2H, s, 9-CH2); 6.93 (2Н, d, J = 7.8, H Ar); 
7.72-8.03 (6H, m, H Ar); 8.76 (1H, s, H-8); 10.24 (1H, s, NH); 10.48 (1H, s, NH) 
  
 
TABLE 4. 13С NMR Spectra of Compounds 4a-g 
 
Chemical shifts, δ, ppm Com-





















127.5; 128.3; 136.7 
4b 127.7 137.7 158.8 141.7 129.2 116.5 42.4 159.2 21.7; 39.4; 120.9; 
126.3; 129.7; 136.2 
4c 127.1 137.1 158.6 143.1 127.9 117.7 42.8 162.9 119.4; 127.4; 
129.7; 136.2 


















 1-(4-Bromophenyl)-4-chloromethyl-1Н-pyrazole-3-carboxylic Acid Ethyl Ester (1c). Yield 86%. 
Mp 96-98°С (EtOH). IR spectrum, ν, cm-1: 1730 (C=O). 1Н NMR spectrum, δ, ppm (J, Hz): 1.34 (3Н, t, J = 7.2, 
CH3); 4.36 (2H, d, J = 7.2, CH2); 4.90 (2Н, s, СН2); 7.73-7.96 (4Н, m, Н Ar); 8.81 (1H, s, H-5). Found, %: 





 4-Azidomethyl-1-methyl(aryl)-1Н-pyrazole-3-carboxylic Acid Ethyl Esters 2а-с (General Method). 
NaN3 (1.62 g 0.025 mol) was added to a solution of 4-chloromethylpyrazole 1а-с (0.01 mol) in DMF (20 ml). The 
mixture was stirred at 50°С for 3 h. The reaction mixture was cooled and poured into ice water (100 ml). The 
formed precipitate (compounds 2b,c) was filtered off, washed with ice water (2×20 ml), dried in air, and re-
crystallized from ethanol. Alternatively, the oily layer (compound 2а) was extracted with CH2Cl2 (2×30 ml), dried 
over anhydrous Na2SO4, and the solvent was removed. An analytically pure oily substance was obtained. 
 1-Methyl(aryl)-5-oxo-4,5,7,9-tetrahydropyrazolo[3,4-е][1,2,3]triazolo[1,5-а][1,3]diazepine-3-carb-
oxamides 4а-g (General Method). Cyanoacetamide 3а-е [14, 15] (0.002 mol) and t-BuOK (0.25 g, 
0.0022 mol) were successively added to a solution of azidomethylcarboxylate 2а-с (0.002 mol) in THF (15 ml). 
The mixture was heated under reflux for 5 h. The solvent was removed by distillation. The residue was 
dissolved in water (30 ml) and acidified with 10% HСl to рН 3. The formed precipitate was filtered off, washed 
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